title: [New topical treatment of atopic dermatitis].
abstract: Topical inhibitors of calcineurin--tacrolimus and pimecrolimus have recently been approved in the treatment of atopic dermatitis. These are the first topical immunosuppressants other than glucocorticosteroids, awaited in dermatology since approximately 50 years. Both medications present similar mechanism of action, good therapeutic and safety profiles and should be considered as important factors in the treatment of atopic dermatitis.
authors.affiliation: Katedra i Klinika Dermatologii oraz Ośrodek Diagnostyki Chorób Alergicznych Akademii Medycznej w Poznaniu.
authors.forename: Magdalena
authors.initials: M
authors.lastname: Czarnecka-Operacz
authors.forename: Wojciech
authors.initials: W
authors.lastname: Silny
mesh_terms: D003876:Dermatitis, Atopic / Q000188:drug therapy*; D006801:Humans; D007166:Immunosuppressive Agents / Q000627:therapeutic use*; D016559:Tacrolimus / Q000627:therapeutic use*
chemical_list: D007166:Immunosuppressive Agents; D016559:Tacrolimus